Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DMTKNASDAQ:MGRXNASDAQ:OTRKNYSE:SSY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDMTKDermTech$0.19$0.09▼$3.90$3.29M2.481.07 million shs3.66 million shsMGRXMangoceuticals$2.03+1.0%$1.88$1.32▼$7.66$10.49M2.75212,492 shs237,172 shsOTRKOntrak$1.43-2.1%$1.53$1.27▼$5.53$6.03M2.38452,437 shs7,116 shsSSYSunLink Health Systems$0.97-4.3%$0.90$0.59▼$1.91$6.81M1.12112,025 shs116,160 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDMTKDermTech0.00%0.00%0.00%0.00%-79.63%MGRXMangoceuticals+1.00%-0.49%+29.71%-48.08%-97.53%OTRKOntrak-2.05%-6.54%-17.05%-1.11%-58.73%SSYSunLink Health Systems-4.26%+8.53%+15.44%-2.72%+28.93%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDMTKDermTechN/AN/AN/AN/AN/AN/AN/AN/AMGRXMangoceuticals0.5121 of 5 stars0.03.00.00.02.11.70.0OTRKOntrak2.5831 of 5 stars3.53.00.00.02.70.01.3SSYSunLink Health Systems1.0725 of 5 stars0.03.00.00.00.61.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDMTKDermTech 0.00N/AN/AN/AMGRXMangoceuticals 0.00N/AN/AN/AOTRKOntrak 3.00Buy$45.003,046.85% UpsideSSYSunLink Health Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDMTKDermTech$15.66M0.00N/AN/A$1.67 per share0.00MGRXMangoceuticals$511.08K20.53N/AN/A$0.54 per share3.76OTRKOntrak$10.18M0.59N/AN/A$5.56 per share0.26SSYSunLink Health Systems$31.09M0.22N/AN/A$2.00 per share0.48Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDMTKDermTech-$100.89M-$2.70N/AN/AN/A-572.19%-138.79%-68.96%N/AMGRXMangoceuticals-$9.21M-$4.64N/A∞N/A-1,237.00%-138.00%-118.88%N/AOTRKOntrak-$27.92M-$15.81N/AN/AN/A-237.77%-171.34%-113.42%8/6/2025 (Estimated)SSYSunLink Health Systems-$1.53M$0.246.91∞N/A3.20%-20.94%-16.09%N/ALatest DMTK, MGRX, SSY, and OTRK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025OTRKOntrak-$1.24-$1.65-$0.41-$1.65N/A$2.02 million5/15/2025Q1 2025MGRXMangoceuticalsN/A-$1.29N/A-$1.29N/A$0.11 million4/14/2025Q4 2024OTRKOntrak-$1.35-$9.54-$8.19-$9.54$3.08 million$3.08 million3/20/2025Q4 2024MGRXMangoceuticalsN/A-$1.01N/A-$1.01N/A$0.11 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDMTKDermTechN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/AOTRKOntrakN/AN/AN/AN/AN/ASSYSunLink Health SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDMTKDermTechN/A3.533.46MGRXMangoceuticalsN/A0.070.07OTRKOntrak0.191.171.17SSYSunLink Health SystemsN/A4.063.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDMTKDermTech20.45%MGRXMangoceuticals56.72%OTRKOntrak12.95%SSYSunLink Health Systems23.67%Insider OwnershipCompanyInsider OwnershipDMTKDermTech5.10%MGRXMangoceuticals16.00%OTRKOntrak1.90%SSYSunLink Health Systems27.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDMTKDermTech26034.96 million33.18 millionOptionableMGRXMangoceuticals35.17 million1.51 millionNot OptionableOTRKOntrak2504.22 million4.14 millionNo DataSSYSunLink Health Systems1,3767.04 million5.08 millionNot OptionableDMTK, MGRX, SSY, and OTRK HeadlinesRecent News About These CompaniesSunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter ResultsMay 13, 2025 | businesswire.comREGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTIONApril 15, 2025 | markets.businessinsider.comSunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter ResultsFebruary 12, 2025 | businesswire.comRegional Health Properties to merge with Sunlink Health SystemsJanuary 8, 2025 | mcknightsseniorliving.comRegional Health, SunLink Health to merge in all-stock transactionJanuary 7, 2025 | markets.businessinsider.comSunLink Health Systems Inc (SSY) Stock Trading RecapJanuary 7, 2025 | bovnews.comRegional Health Properties Shares More Than Double on SunLink Health DealJanuary 6, 2025 | marketwatch.comShareholder Alert: Ademi LLP Investigates Whether SunLink Health Systems, Inc. Is Obtaining a Fair Price for Its Public ShareholdersJanuary 6, 2025 | stockhouse.comSSY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of SunLink Health Systems, Inc. Is Fair to ShareholdersJanuary 6, 2025 | tmcnet.comSunLink Health Systems Inc (SSY) Stock: Beyond the Surface of Its Performance?December 27, 2024 | bovnews.comSunLink Health Systems IncNovember 18, 2024 | uk.investing.comSunLink Health Systems, Inc. Announces Fiscal 2025 First Quarter ResultsNovember 13, 2024 | accesswdun.comJPMorgan, Wells Fargo And 3 Stocks To Watch Heading Into FridayOctober 12, 2024 | msn.comSunLink Health Systems, Inc. Announces Sale of Trace Regional Hospital Real EstateOctober 10, 2024 | finance.yahoo.comSunLink Health Systems (AMEX:SSY) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comSunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual ResultsSeptember 30, 2024 | businesswire.comSunLink Health Systems, Inc. (SSY)August 1, 2024 | finance.yahoo.comSunLink Health Systems, Inc. Announces Sale of Trace Extended Care & RehabJune 3, 2024 | businesswire.comSSY Stock Earnings: SunLink Health Systems Reported Results for Q3 2024May 16, 2024 | investorplace.comSunLink Health Systems, Inc. Announces Fiscal 2024 Third Quarter ResultsMay 15, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDMTK, MGRX, SSY, and OTRK Company DescriptionsDermTech NASDAQ:DMTKDermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the psoriasis, atopic dermatitis, and aging of the skin to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California.Mangoceuticals NASDAQ:MGRX$2.03 +0.02 (+1.00%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.02 0.00 (-0.25%) As of 06/13/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.Ontrak NASDAQ:OTRK$1.43 -0.03 (-2.05%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.45 +0.02 (+1.68%) As of 06/13/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.SunLink Health Systems NYSE:SSY$0.97 -0.04 (-4.26%) Closing price 06/13/2025 03:56 PM EasternExtended Trading$1.00 +0.03 (+3.41%) As of 06/13/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
